Package 0078-0690-61

Brand: arzerra

Generic: ofatumumab
NDC Package

Package Facts

Identity

Package NDC 0078-0690-61
Digits Only 0078069061
Product NDC 0078-0690
Product ID 0078-0690_08c0da18-b3bb-4d78-9d74-00e947f39135
Description

50 mL in 1 VIAL, SINGLE-USE (0078-0690-61)

Marketing

Marketing Status
Discontinued 2026-03-31
Brand arzerra
Generic ofatumumab
Sample Package No

Linked Drug Pages (1)

ARZERRA ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "08c0da18-b3bb-4d78-9d74-00e947f39135", "openfda": {"nui": ["N0000175657", "N0000175078"], "unii": ["M95KG522R0"], "rxcui": ["1658042", "1658044", "1658047", "1658048"], "spl_set_id": ["77785ce3-e8df-4ca1-8f8e-6c418c6a17de"], "pharm_class_epc": ["CD20-directed Cytolytic Antibody [EPC]"], "pharm_class_moa": ["CD20-directed Antibody Interactions [MoA]"], "manufacturer_name": ["Novartis Pharmaceuticals Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "50 mL in 1 VIAL, SINGLE-USE (0078-0690-61)", "package_ndc": "0078-0690-61", "marketing_end_date": "20260331", "marketing_start_date": "20160201"}], "brand_name": "ARZERRA", "product_id": "0078-0690_08c0da18-b3bb-4d78-9d74-00e947f39135", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["CD20-directed Antibody Interactions [MoA]", "CD20-directed Cytolytic Antibody [EPC]"], "product_ndc": "0078-0690", "generic_name": "ofatumumab", "labeler_name": "Novartis Pharmaceuticals Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ARZERRA", "active_ingredients": [{"name": "OFATUMUMAB", "strength": "20 mg/mL"}], "application_number": "BLA125326", "marketing_category": "BLA", "marketing_end_date": "20260331", "marketing_start_date": "20160201"}